Skip to Main Content

Paper Details

Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.
Clin Lymphoma Myeloma Leuk
8
2022
Author NameAffiliation
Moshe TalpazUniversity of Michigan Rogel Cancer Center ann arbor
  • 1 - 1

Datasets

Release 1.2